Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Levitan

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Journal of Clinical Psychopharmacology|August 15, 2018
Tranylcypromine Plus Amitriptyline for Electroconvulsive Therapy-Resistant Depression: A Long-Term StudyRafael Ferreira-Garcia, Rafael Christophe da Rocha Freire, José Carlos Appolinário, et al.
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii|September 22, 2007
[Level of natural autoantibodies to interferon-alpha and characteristics of interferon status during chronic hepatitis and liver cirrhosis]A V Astakhin, E E Efimova, V V Zverev, et al.
Cancer Chemotherapy and Pharmacology|March 28, 2001
Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancerA Dowlati, N Levitan, N H Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapyF A Shepherd, J Dancey, R Ramlau, et al.
Journal of Clinical Psychopharmacology|December 20, 2021
Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake InhibitorsFiammetta Cosci, Sara Romanazzo, Giovanni Mansueto, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|October 6, 2011
[Guidelines of the Brazilian Medical Association for the treatment of social anxiety disorder]Michelle N Levitan, Marcos H N Chagas, José A S Crippa, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|February 11, 2011
[Guidelines of the Brazilian Medical Association for the diagnosis and differential diagnosis of social anxiety disorder]Marcos Hortes N Chagas, Antonio E Nardi, Gisele G Manfro, et al.
Journal of Affective Disorders|July 3, 2007
Demographic and clinical features of panic disorder comorbid with bipolar I disorder: a 3-year retrospective studyAntonio Egidio Nardi, Isabella Nascimento, Rafael C Freire, et al.
Journal of Clinical Psychopharmacology|May 18, 2010
Tapering clonazepam in patients with panic disorder after at least 3 years of treatmentAntonio E Nardi, Rafael C Freire, Alexandre M Valença, et al.
Journal of Clinical Psychopharmacology|March 3, 2011
Randomized, open naturalistic, acute treatment of panic disorder with clonazepam or paroxetineAntonio E Nardi, Alexandre M Valença, Rafael C Freire, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of Clinical Psychopharmacology|August 15, 2018
Tranylcypromine Plus Amitriptyline for Electroconvulsive Therapy-Resistant Depression: A Long-Term StudyRafael Ferreira-Garcia, Rafael Christophe da Rocha Freire, José Carlos Appolinário, et al.
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii|September 22, 2007
[Level of natural autoantibodies to interferon-alpha and characteristics of interferon status during chronic hepatitis and liver cirrhosis]A V Astakhin, E E Efimova, V V Zverev, et al.
Cancer Chemotherapy and Pharmacology|March 28, 2001
Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancerA Dowlati, N Levitan, N H Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapyF A Shepherd, J Dancey, R Ramlau, et al.
Journal of Clinical Psychopharmacology|December 20, 2021
Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake InhibitorsFiammetta Cosci, Sara Romanazzo, Giovanni Mansueto, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|October 6, 2011
[Guidelines of the Brazilian Medical Association for the treatment of social anxiety disorder]Michelle N Levitan, Marcos H N Chagas, José A S Crippa, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|February 11, 2011
[Guidelines of the Brazilian Medical Association for the diagnosis and differential diagnosis of social anxiety disorder]Marcos Hortes N Chagas, Antonio E Nardi, Gisele G Manfro, et al.
Journal of Affective Disorders|July 3, 2007
Demographic and clinical features of panic disorder comorbid with bipolar I disorder: a 3-year retrospective studyAntonio Egidio Nardi, Isabella Nascimento, Rafael C Freire, et al.
Journal of Clinical Psychopharmacology|May 18, 2010
Tapering clonazepam in patients with panic disorder after at least 3 years of treatmentAntonio E Nardi, Rafael C Freire, Alexandre M Valença, et al.
Journal of Clinical Psychopharmacology|March 3, 2011
Randomized, open naturalistic, acute treatment of panic disorder with clonazepam or paroxetineAntonio E Nardi, Alexandre M Valença, Rafael C Freire, et al.
Pageof 6